BB
BB Biotech Portfolio holdings
AUM
$3.98B
This Quarter Return
+17.86%
1 Year Return
+15.06%
3 Year Return
+120.36%
5 Year Return
+263.74%
10 Year Return
–
AUM
$3.06B
AUM Growth
+$3.06B
(+13%)
Cap. Flow
-$7.88M
Cap. Flow
% of AUM
-0.26%
Top 10 Holdings %
Top 10 Hldgs %
74.76%
Holding
30
New
1
Increased
13
Reduced
6
Closed
–
Top Buys
| 1 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$26.3M |
| 2 |
Ionis Pharmaceuticals
IONS
|
$22M |
| 3 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$6.99M |
| 4 |
RDUS
Radius Health, Inc.
RDUS
|
$6.96M |
| 5 |
MacroGenics
MGNX
|
$6.32M |
Top Sells
| 1 |
Incyte
INCY
|
$52.1M |
| 2 |
TSRO
TESARO, Inc.
TSRO
|
$23.1M |
| 3 |
CELG
Celgene Corp
CELG
|
$14.9M |
| 4 |
KITE
Kite Pharma, Inc.
KITE
|
$4.71M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
$3.55M |
Sector Composition
| 1 | Healthcare | 90.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Novavax
NVAX
$1.21B
| $10.7M | 0.35% |
8,330,000
| – | – |
|
27
Puma Biotechnology
PBYI
$254M
| $9.14M | 0.3% |
245,616
+3,625
| +1% | +$135K |
|
28
Cidara Therapeutics
CDTX
$1.66B
| $8.14M | 0.27% |
1,043,824
| – | – |
|
29
PTC Therapeutics
PTCT
$3.92B
| $6.72M | 0.22% |
682,912
| – | – |
|
|
ACHN
30
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $5.39M | 0.18% |
1,279,340
| – | – |
|